| Date | Time | Source | Headline | Symbol | Company |
| 04/29/2009 | 7:00AM | PR Newswire (US) | Wyeth Reports Earnings Results for the 2009 First Quarter | NYSE:WYE | Wyeth |
| 04/28/2009 | 6:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:WYE | Wyeth |
| 04/28/2009 | 2:16PM | Dow Jones News | 2nd UPDATE: Pfizer's, Bristol's 1Q Profits Are Mixed | NYSE:WYE | Wyeth |
| 04/28/2009 | 1:47PM | Dow Jones News | UPDATE: Hospira 1Q Net More Than Doubles On Tax-Related Gain | NYSE:WYE | Wyeth |
| 04/28/2009 | 1:02PM | Dow Jones News | WHO To Avoid Tuberculosis Drugs Made By Wyeth In Pakistan | NYSE:WYE | Wyeth |
| 04/28/2009 | 1:01PM | Dow Jones News | UPDATE: Pfizer, Bristol 1Q Profits Mixed On Forex, Generics | NYSE:WYE | Wyeth |
| 04/28/2009 | 10:52AM | Dow Jones News | Pfizer, Bristol 1Q Profits Mixed On Forex, Generic Pressure | NYSE:WYE | Wyeth |
| 04/28/2009 | 9:20AM | PR Newswire (US) | Beacon Equity Issues Stock Alerts on Market Movers: TKR, NVDA, SBUX, PFE, WAG, WYE | NYSE:WYE | Wyeth |
| 04/28/2009 | 8:15AM | Dow Jones News | Pfizer 1Q Net Down 2% Amid Forex, Generic Competition | NYSE:WYE | Wyeth |
| 04/27/2009 | 9:00AM | PR Newswire (US) | Wyeth's CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fract | NYSE:WYE | Wyeth |
| 04/27/2009 | 8:14AM | Dow Jones News | UPDATE: Imperial Innovations Gets 1st Half Boost From Thiakis Sale | NYSE:WYE | Wyeth |
| 04/23/2009 | 7:06PM | Dow Jones News | 2nd UPDATE: Amgen 1Q Profit Drops 7.4%; Cuts '09 Revenue View | NYSE:WYE | Wyeth |
| 04/23/2009 | 6:23PM | Dow Jones News | UPDATE: Amgen 1Q Profit Drops 7.4%; Cuts '09 Revenue View | NYSE:WYE | Wyeth |
| 04/23/2009 | 5:11PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:WYE | Wyeth |
| 04/23/2009 | 5:10PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NYSE:WYE | Wyeth |
| 04/23/2009 | 3:33PM | Dow Jones News | Pfizer's Shareholders Approve Say-On-Pay; J&J's Say No Thanks | NYSE:WYE | Wyeth |
| 04/23/2009 | 2:40PM | PR Newswire (US) | Wyeth Announces Full Redemption of $2 Convertible Preferred Stock | NYSE:WYE | Wyeth |
| 04/23/2009 | 12:47PM | PR Newswire (US) | Wyeth Declares Common and Preferred Stock Dividends | NYSE:WYE | Wyeth |
| 04/23/2009 | 10:03AM | Marketwired | TheFortuneFinancial.com Initializes Free Analyst Research on AGU, WYE, KEY and FLS | NYSE:WYE | Wyeth |
| 04/22/2009 | 4:30PM | Dow Jones News | US Drug Market To Shrink In 2009, Global Growth Slowing -IMS | NYSE:WYE | Wyeth |
| 04/22/2009 | 4:14PM | Dow Jones News | CORRECT: Wyeth: Rwanda Using Prevenar In Immunization Program | NYSE:WYE | Wyeth |
| 04/22/2009 | 3:37PM | Dow Jones News | Wyeth: Rwanda Using Prevenar In Immunization Program | NYSE:WYE | Wyeth |
| 04/22/2009 | 1:39PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:WYE | Wyeth |
| 04/21/2009 | 12:02PM | Dow Jones News | CORRECT: =Merck 1Q Net Down 56% Amid Year-Ago Gain, Sales Drop | NYSE:WYE | Wyeth |
| 04/21/2009 | 8:07AM | Dow Jones News | Merck 1Q Net Down 56% Amid Year-Ago Gain, Sales Drop | NYSE:WYE | Wyeth |
| 04/17/2009 | 9:00AM | PR Newswire (US) | New Partnerships Added to World Federation of Hemophilia Twinning Program | NYSE:WYE | Wyeth |
| 04/15/2009 | 12:54PM | Dow Jones News | Big Pharma Sees Value In Using Small Drug Discovery Units | NYSE:WYE | Wyeth |
| 04/15/2009 | 11:47AM | Dow Jones News | 2nd UPDATE: Abbott Labs 1Q Net Up 53% On JV Gain Despite Weak Sales | NYSE:WYE | Wyeth |
| 04/15/2009 | 11:08AM | Dow Jones News | UPDATE: Abbott Labs CEO: Not Evaluating Any Large Deals | NYSE:WYE | Wyeth |
| 04/15/2009 | 10:29AM | Dow Jones News | Abbott Labs CEO: Not Evaluating Any Large Deals | NYSE:WYE | Wyeth |